1. Home
  2. Analysis
  3. Aprepitant
  4. Interstitial-lung-disease

Aprepitant and Interstitial lung disease - a phase IV clinical study of FDA data

Summary:

Interstitial lung disease is reported as a side effect among people who take Aprepitant (aprepitant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Prednisone, and have Nausea and vomiting.

The phase IV clinical study analyzes which people have Interstitial lung disease when taking Aprepitant. It is created by eHealthMe based on reports of 6,989 people who have side effects when taking Aprepitant from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,500 drugs and 1,841 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

6,989 people reported to have side effects when taking Aprepitant.
Among them, 80 people (1.14%) have Interstitial lung disease.

Could Aprepitant cause Interstitial lung disease?

Among these 80 people:

How long have people been on Aprepitant when they have Interstitial lung disease? *

  • < 1 month: 35.29 %
  • 1 - 6 months: 47.06 %
  • 6 - 12 months: 17.65 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Interstitial lung disease when taking Aprepitant? *

  • female: 53.73 %
  • male: 46.27 %

What is the age of people who have Interstitial lung disease when taking Aprepitant? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 27.69 %
  • 50-59: 13.85 %
  • 60+: 58.46 %

What are other drugs people take besides Aprepitant? *

  1. Folic Acid: 17 people, 21.25%
  2. Lansoprazole: 17 people, 21.25%
  3. Prednisone: 17 people, 21.25%
  4. Furosemide: 15 people, 18.75%
  5. Dexamethasone Sodium Phosphate: 14 people, 17.50%
  6. Enhertu: 14 people, 17.50%
  7. Decadron: 13 people, 16.25%
  8. Dexamethasone: 13 people, 16.25%
  9. Oxycodone: 12 people, 15.00%
  10. Allopurinol: 12 people, 15.00%

What are other side effects people have besides Interstitial lung disease? *

  1. Fever: 11 people, 13.75%
  2. Lung Disorder (lung disease): 11 people, 13.75%
  3. Malaise (a feeling of general discomfort or uneasiness): 10 people, 12.50%
  4. Dyspnea (difficult or laboured breathing): 10 people, 12.50%
  5. Fatigue (feeling of tiredness): 9 people, 11.25%
  6. Nausea (feeling of having an urge to vomit): 9 people, 11.25%
  7. Infusion Related Reaction: 9 people, 11.25%
  8. Cough: 9 people, 11.25%
  9. Nodule (a growth of abnormal tissue): 8 people, 10.00%
  10. Pain In Extremity: 8 people, 10.00%

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 13 people, 16.25%
  2. Constipation: 10 people, 12.50%
  3. Inflammation: 8 people, 10.00%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 10.00%
  5. Nausea (feeling of having an urge to vomit): 8 people, 10.00%
  6. Stomatitis (inflammation of mucous membrane of mouth): 8 people, 10.00%
  7. Back Pain: 8 people, 10.00%
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 8 people, 10.00%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 10.00%
  10. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and have Interstitial lung disease?

- Check whether Interstitial lung disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aprepitant:

Interstitial lung disease treatments and more:

How severe was Interstitial lung disease and when was it recovered:

Expand to all the drugs that have ingredients of aprepitant:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Interstitial lung disease:

Browse all the conditions that are associated with Interstitial lung disease:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant (the active ingredients of Aprepitant) and Aprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.